BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30760105)

  • 21. Temporal patterns of macrophage- and neutrophil-related markers are associated with clinical outcome in heart failure patients.
    Klimczak-Tomaniak D; Bouwens E; Schuurman AS; Akkerhuis KM; Constantinescu A; Brugts J; Westenbrink BD; van Ramshorst J; Germans T; Pączek L; Umans V; Boersma E; Kardys I
    ESC Heart Fail; 2020 Jun; 7(3):1190-1200. PubMed ID: 32196993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.
    van der Velde AR; Gullestad L; Ueland T; Aukrust P; Guo Y; Adourian A; Muntendam P; van Veldhuisen DJ; de Boer RA
    Circ Heart Fail; 2013 Mar; 6(2):219-26. PubMed ID: 23395934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.
    O'Meara E; Rouleau JL; White M; Roy K; Blondeau L; Ducharme A; Neagoe PE; Sirois MG; Lavoie J; Racine N; Liszkowski M; Madore F; Tardif JC; de Denus S;
    Circ Heart Fail; 2014 Sep; 7(5):773-81. PubMed ID: 25027873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of biomarkers of cardiac remodeling, myofibrosis, and inflammation in assessment of disease severity in euvolemic patients with chronic stable heart failure.
    Andreasová T; Vránová J; Vondráková D; Sedláčková L; Zákostelská ZJ; Neužil P; Málek F
    J Int Med Res; 2020 Aug; 48(8):300060520947869. PubMed ID: 32815444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
    Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A
    Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
    Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L
    Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Yang J
    Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.
    van den Bosch E; Bossers SSM; Kamphuis VP; Boersma E; Roos-Hesselink JW; Breur JMPJ; Ten Harkel ADJ; Kapusta L; Bartelds B; Roest AAW; Kuipers IM; Blom NA; Koopman LP; Helbing WA
    J Am Heart Assoc; 2021 Feb; 10(5):e015022. PubMed ID: 33624507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The Prognostic Role of Biomarkers in Patients With Chronic Heart Failure].
    Kurlianskaya EK; Mrochek AG; Denisevich TL; Kaliadka MG; Russkich II
    Kardiologiia; 2020 Feb; 60(1):16-22. PubMed ID: 32245350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
    Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
    Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study).
    Klimczak-Tomaniak D; de Bakker M; Bouwens E; Akkerhuis KM; Baart S; Rizopoulos D; Mouthaan H; van Ramshorst J; Germans T; Constantinescu A; Manintveld O; Umans V; Boersma E; Kardys I
    Sci Rep; 2022 Feb; 12(1):2795. PubMed ID: 35181700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of spontaneous reverse remodeling in mild heart failure patients with left ventricular dysfunction.
    Brenyo A; Barsheshet A; Kutyifa V; Ruwald AC; Rao M; Zareba W; Pouleur AC; Knappe D; Solomon SD; McNitt S; Huang DT; Moss AJ; Goldenberg I
    Circ Heart Fail; 2014 Jul; 7(4):565-72. PubMed ID: 24786217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial galectin-3 and future cardiovascular disease in the general population.
    van der Velde AR; Meijers WC; Ho JE; Brouwers FP; Rienstra M; Bakker SJ; Muller Kobold AC; van Veldhuisen DJ; van Gilst WH; van der Harst P; de Boer RA
    Heart; 2016 Jul; 102(14):1134-41. PubMed ID: 27084804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
    Srivatsan V; George M; Shanmugam E
    Eur J Prev Cardiol; 2015 Sep; 22(9):1096-110. PubMed ID: 25268020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up study.
    Volpe M; Francia P; Tocci G; Rubattu S; Cangianiello S; Elena Rao MA; Trimarco B; Condorelli M
    Clin Cardiol; 2010 Nov; 33(11):700-7. PubMed ID: 21089115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serially Measured Cytokines and Cytokine Receptors in Relation to Clinical Outcome in Patients With Stable Heart Failure.
    Bouwens E; Schuurman AS; Akkerhuis KM; Baart SJ; Caliskan K; Brugts JJ; van Ramshorst J; Germans T; Umans VAWM; Boersma E; Kardys I
    Can J Cardiol; 2020 Oct; 36(10):1587-1591. PubMed ID: 32827637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
    Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of plasma ghrelin in predicting the outcome of patients with chronic heart failure.
    Chen Y; Ji XW; Zhang AY; Lv JC; Zhang JG; Zhao CH
    Arch Med Res; 2014 Apr; 45(3):263-9. PubMed ID: 24508287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.